Cite
Design and Discovery of N-(2-Methyl-5'-morpholino-6'-((tetrahydro-2H-pyran-4-yl)oxy)-[3,3'-bipyridin]-5-yl)-3-(trifluoromethyl)benzamide (RAF709): A Potent, Selective, and Efficacious RAF Inhibitor Targeting RAS Mutant Cancers
MLA
Yan Lou, et al. “Design and Discovery of N-(2-Methyl-5’-Morpholino-6’-((Tetrahydro-2H-Pyran-4-Yl)Oxy)-[3,3’-Bipyridin]-5-Yl)-3-(Trifluoromethyl)Benzamide (RAF709): A Potent, Selective, and Efficacious RAF Inhibitor Targeting RAS Mutant Cancers.” Journal of Medicinal Chemistry, vol. 60, no. 12, May 2017. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d2623e531b4911ee04267b3f1e132c67&authtype=sso&custid=ns315887.
APA
Yan Lou, Sharadha Subramanian, Yingyun Wang, Lifeng Wan, John Tellew, Laura Tandeske, Benjamin R. Taft, Kalyani Gampa, Jacob R. Haling, Gisele Nishiguchi, Lina Setti, Alice Rico, Sylvia Ma, Payman Amiri, Mallika Singh, Huw Tanner, Brent A. Appleton, Robert J. Aversa, Sepideh Vaziri, … Mohammad Hekmat-Nejad. (2017). Design and Discovery of N-(2-Methyl-5’-morpholino-6’-((tetrahydro-2H-pyran-4-yl)oxy)-[3,3’-bipyridin]-5-yl)-3-(trifluoromethyl)benzamide (RAF709): A Potent, Selective, and Efficacious RAF Inhibitor Targeting RAS Mutant Cancers. Journal of Medicinal Chemistry, 60(12).
Chicago
Yan Lou, Sharadha Subramanian, Yingyun Wang, Lifeng Wan, John Tellew, Laura Tandeske, Benjamin R. Taft, et al. 2017. “Design and Discovery of N-(2-Methyl-5’-Morpholino-6’-((Tetrahydro-2H-Pyran-4-Yl)Oxy)-[3,3’-Bipyridin]-5-Yl)-3-(Trifluoromethyl)Benzamide (RAF709): A Potent, Selective, and Efficacious RAF Inhibitor Targeting RAS Mutant Cancers.” Journal of Medicinal Chemistry 60 (12). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d2623e531b4911ee04267b3f1e132c67&authtype=sso&custid=ns315887.